Assessment of the In Vitro Biological Activities of Schiff Base-Synthesized Copper Oxide Nanoparticles as an Anti-Diabetic, Anti-Alzheimer, and Anti-Cancer Agent
Pharmaceutics · 01.02.2025 · 17 (2) · 180
DOI: 10.3390/pharmaceutics17020180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 01.02.2025. Verfasst von Abdulrahman A Almehizia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Drug Exploration and Development Chair (DEDC), Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riya…. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.
Themen: Demenz
Abstract (Originalsprache)
Background/Objectives: Numerous diseases such as diabetes, Alzheimer’s disease, and cancer have spread in the whole world, especially in the Arab world. Also, various applications of Schiff-base functionalized nanoparticles and copper oxide nanoparticles (CuO-NPs) such as therapeutic applications have been discovered. Thus, the current research highlights (i) the synthesis of copper oxide nanoparticles (CuO-NPs) produced with a Schiff base (SB) serving as a capping agent during their synthesis and (ii) assessment of the in vitro biological activities of Schiff base-synthesized copper oxide nanoparticles (SB-CuO-NPs) and a Schiff base (SB).
Methods
SB-CuO-NPs were characterized using ultraviolet-visible (UV-Vis) spectroscopy, zeta potential, DLS analysis, and transmission electron microscope (TEM). It also focuses on assessing the in vitro biological applications and activities, including antioxidant, scavenging, anti-diabetic, anti-Alzheimer, anti-arthritic, anti-inflammatory, cytotoxic activities, and enzymes inhibitory potential, of Schiff base-synthesized copper oxide nanoparticles (SB-CuO-NPs) and a Schiff base (SB) using methods described in the literature.
Results
The results of the biological activities of the SB-CuO-NPs were compared with those of the SB. The SB-CuO-NPs demonstrated superior in vitro biological activities when compared to the SB from which they were produced.
Conclusions
The results of this investigation concluded that the CuO-NPs, synthesized with the SB serving as an alternative capping agent, exhibited enhanced biological efficacy relative to the original SB. In the future, the biological efficiency of SB-CuO-NPs against diabetes, Alzheimer’s, and cancer diseases will be assessed in experimental animals (in vivo).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Drug Exploration and Development Chair (DEDC), Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
- Organometallic and Organometalloid Chemistry Department, National Research Centre, Dokki, Cairo 12622, Egypt.
- Biochemistry Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt.
ORCID-Profile: Abdulrahman A Almehizia, Ahmed M Naglah, Ashraf S Hassan
Förderung
- King Saud University
Zitieren
APA
Almehizia, A. A., Naglah, A. M., Aljafen, S. S., Hassan, A. S., & Aboulthana, W. M. (2025). Assessment of the In Vitro Biological Activities of Schiff Base-Synthesized Copper Oxide Nanoparticles as an Anti-Diabetic, Anti-Alzheimer, and Anti-Cancer Agent. Pharmaceutics, 17(2), 180. https://doi.org/10.3390/pharmaceutics17020180
Vancouver
Almehizia AA, Naglah AM, Aljafen SS, Hassan AS, Aboulthana WM. Assessment of the In Vitro Biological Activities of Schiff Base-Synthesized Copper Oxide Nanoparticles as an Anti-Diabetic, Anti-Alzheimer, and Anti-Cancer Agent. Pharmaceutics. 2025;17(2):180. doi:10.3390/pharmaceutics17020180
BibTeX
@article{Almehizia2025,
author = {Almehizia, Abdulrahman A and Naglah, Ahmed M and Aljafen, Sadeem S and Hassan, Ashraf S and Aboulthana, Wael M},
title = {Assessment of the In Vitro Biological Activities of Schiff Base-Synthesized Copper Oxide Nanoparticles as an Anti-Diabetic, Anti-Alzheimer, and Anti-Cancer Agent},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {2},
pages = {180},
doi = {10.3390/pharmaceutics17020180}
}
EUVIMED